What does CUSIP 738920115 represent in this 13F holders report?

CUSIP 738920115 is the security identifier for ASBPW - Aspire Biopharma Holdings, Inc. - *W EXP 02/14/203 used to aggregate holder disclosures.

How many institutions held ASBPW - Aspire Biopharma Holdings, Inc. - *W EXP 02/14/203 in Q2 2025?

28 institutional investors reported ASBPW - Aspire Biopharma Holdings, Inc. - *W EXP 02/14/203 for Q2 2025. Use the holders table for investor-level position and value details.

203 (ASBPW)

CUSIP: 738920115

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / *W EXP 02/14/203
Total 13F shares: 9,048,414
Total 13F value: $411,598
Share change: +532,836
SEC-reported price per share: $0.04
Number of holders: 28
Value change: +$23,962
Number of buys: 5
Number of sells: 4

Security key

738920115

Report period

Q2 2025

Institutions

Top holders

ASBPW full security history Ownership snapshot Full 13F holder table Aspire Biopharma Holdings, Inc. SEC filings Aspire Biopharma Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ASBPW - Aspire Biopharma Holdings, Inc. - *W EXP 02/14/203 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Lance Friedman

Disclosed value leader

Lance Friedman

Comparable rows

14/15

Latest evidence

04 Jun 2025

13D/G 13F 3/4/5 Lead comparable stake: 4.5% 1 rows are not safely comparable across share classes. 13D/G row: Lance Friedman Showing 1-6 of 15 holder rows.

Quick read

Lance Friedman leads the comparable SEC ownership view at 4.5%.

14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lance Friedman's linked filing trail.

Comparable ownership Top 5

Lance Friedman 4.5%

Harraden Circle Investments, LLC 0.31%

Donald G. Fell 0.38%

TORONTO DOMINION BANK 9.8%

Crewe Advisors LLC 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Lance Friedman	13D/G 13D/G	4.5%	$1,037,706 2,207,886 shares	-$782,315	06 May 2025
Harraden Circle Investments, LLC	13F 13D/G Company 13F 13D/G	0.31% from 13D/G	$87,390 150,000 shares	—	31 Mar 2025
Donald G. Fell	3/4/5 Director 3/4/5	0.38%	$7,800 20,000 shares	—	04 Jun 2025
TORONTO DOMINION BANK	13F Company 13F	9.8%	$349,904 516,845 shares	—	31 Mar 2025
Crewe Advisors LLC	13F Company 13F	6%	$182,603 313,427 shares	—	31 Mar 2025
Optivise Advisory Services LLC	13F Company 13F	2%	$62,015 106,446 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,048,414

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %